Bio Essence Corporation
BIOE
$0.18
-$0.07-27.96%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -66.17% | 981.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -66.17% | 981.51% | |||
| Cost of Revenue | -46.07% | 719.51% | |||
| Gross Profit | -72.07% | 1,093.53% | |||
| SG&A Expenses | -8.96% | 39.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -36.71% | 267.18% | |||
| Operating Income | -79.04% | 7,100.00% | |||
| Income Before Tax | -79.09% | 7,816.15% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -80.04% | 7,816.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -80.04% | 7,816.15% | |||
| EBIT | -79.04% | 7,100.00% | |||
| EBITDA | -79.03% | 7,100.70% | |||
| EPS Basic | -83.03% | 8,933.33% | |||
| Normalized Basic EPS | -82.25% | 8,350.00% | |||
| EPS Diluted | -90.91% | 16,766.67% | |||
| Normalized Diluted EPS | -82.25% | 8,350.00% | |||
| Average Basic Shares Outstanding | 18.26% | 0.00% | |||
| Average Diluted Shares Outstanding | 18.26% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||